Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 22:2022:3448618.
doi: 10.1155/2022/3448618. eCollection 2022.

The Influence of Different Types of Diabetes on Vascular Complications

Affiliations
Review

The Influence of Different Types of Diabetes on Vascular Complications

Jiahua Wei et al. J Diabetes Res. .

Abstract

The final outcome of diabetes is chronic complications, of which vascular complications are the most serious, which is the main cause of death for diabetic patients and the direct cause of the increase in the cost of diabetes. Type 1 and type 2 diabetes are the main types of diabetes, and their pathogenesis is completely different. Type 1 diabetes is caused by genetics and immunity to destroy a large number of β cells, and insulin secretion is absolutely insufficient, which is more prone to microvascular complications. Type 2 diabetes is dominated by insulin resistance, leading to atherosclerosis, which is more likely to progress to macrovascular complications. This article explores the pathogenesis of two types of diabetes, analyzes the pathogenesis of different vascular complications, and tries to explain the different trends in the progression of different types of diabetes to vascular complications, in order to better prevent diabetes and its vascular complications.

PubMed Disclaimer

Conflict of interest statement

The authors report no declarations of interest.

Figures

Figure 1
Figure 1
Mechanisms of T1DM and microvascular complications.
Figure 2
Figure 2
Mechanisms of T2DM and macrovascular complications.

References

    1. Cho N. H., Shaw J. E., Karuranga S., et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice . 2018;138:271–281. doi: 10.1016/j.diabres.2018.02.023. - DOI - PubMed
    1. Forbes J. M., Fotheringham A. K. Vascular complications in diabetes: old messages, new thoughts. Diabetologia . 2017;60(11):2129–2138. - PubMed
    1. Li H. X., Lu W. H., Wang A., Jiang H., Lyu J. Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: estimates from Global Burden of Disease 2017. Journal of diabetes investigation . 2021;12(3):346–356. doi: 10.1111/jdi.13355. - DOI - PMC - PubMed
    1. Wong Y. T., Cheung C. M. G., Larsen M., Sharma S., Simó R. diabetic retinopathy. Nature Reviews Disease Primers . 2016;6, article 16030 - PubMed
    1. Forbes J. M., Cooper M. E. Mechanisms of diabetic complications. Physiological Reviews . 2013;93(1):137–188. - PubMed